Skip to main content

Closed

ALKS: Alkermes plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

No data

Operating margin7.0%

ROIC2.1%

Financially safe

Adequate

Debt / equity0.87×

Interest coverage2.0×

Current ratio2.30×

Valuation

Unrated

P/E ratio124.1×

Alkermes plc

ALKSNASDAQ·USD·Closed

Alkermes plc

ALKSNASDAQ·USD·Closed

$48.99

−2.08%

$48.99

−$1.04 (2.08%)

52W Range

78thpctl

Volume

0.70×avg

Mkt Cap

8.22BUSD

P/E

124.1TTM

Div Yield

–ann

52W Range

78thpctl

Volume

0.70×avg

Market Cap

8.22BUSD

P/E Ratio

124.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings